From Financialexpress · Oliviya Kunjumon · · 2m
Top 10 Stocks with 19-73% Upside
Brokerages project 19% to 73% returns on 10 Indian stocks this week.
In brief
Brokerages project 19% to 73% returns on 10 Indian stocks this week. Brokerages target 19% to 73% price increases for 10 Indian stocks including PVR Inox, HDFC Bank, and TCS. Originally reported by Financialexpress.
Market Ends Positive
The Indian stock market ended the latest trading week in positive territory with the Nifty 50 gaining 0.44% and Sensex rising 0.78% despite global uncertainty.
PVR Inox: 73% Upside
CLSA sees 73% potential upside for PVR Inox with a target price of Rs 2,135 based on stronger cinema footfalls and growing consumer demand for physical entertainment.
HDFC Bank: 70% Upside
Emkay projects 70% upside for HDFC Bank with a target price of Rs 1,225 as the bank’s valuation becomes attractive after prolonged underperformance.
TCI Express: 56% Upside
Jefferies forecasts 56% upside for TCI Express with a target price of Rs 770 based on expected 10% year-on-year revenue growth and improved truck utilisation.
Mahindra & Mahindra: 49% Upside
Citi targets 49% upside for Mahindra & Mahindra with a target price of Rs 4,260 based on expected growth in passenger and commercial vehicle volumes.
Shyam Metalics: 45% Upside
UBS sees 45% upside for Shyam Metalics with a target price of Rs 1,550 after raising its estimate for capital expenditure efficiency and value-added products.
Adani Enterprises: 36% Upside
Jefferies projects 36% upside for Adani Enterprises with a target price of Rs 3,830 focusing on airport redevelopment and operational efficiency.
Torrent Pharmaceuticals: 24.7% Upside
JPMorgan targets 24.7% upside for Torrent Pharmaceuticals with a target price of Rs 5,950 after integrating JB Pharma’s chronic therapies.
Tata Consultancy Services: 21% Upside
Nomura forecasts 21% upside for TCS with a target price of Rs 2,630 despite reduced earnings growth estimates for FY27.
Cipla: 19.5% Upside
JPMorgan targets 19.5% upside for Cipla with a target price of Rs 1,600 based on expected growth in respiratory and cardiovascular treatments.
Molbio Diagnostics: 19% Upside
Motilal Oswal sees 19% upside for Molbio Diagnostics with a target price of Rs 1,800 based on expanding tuberculosis testing and new assays.
Stock Market Activity
Brokerages project 19% to 73% returns on 10 Indian stocks this week with varying growth drivers across sectors.
Market Reaction
The Indian stock market ended the latest trading week in positive territory with the Nifty 50 gaining 0.44% and Sensex rising 0.78% despite global uncertainty.
The essence
Brokerages target 19% to 73% price increases for 10 Indian stocks including PVR Inox, HDFC Bank, and TCS.
